U.S. Drug Discovery Outsourcing Market (2025 - 2033) Size, Share & Trends Analysis Report By Workflow (Target Identification & Screening, Target Validation & Functional Informatics), By Drug, By Service, By Therapeutics Area, By End Use, And Segment Forecasts

Table of Contents

Chapter 1. Research Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Workflow
                       1.2.2. Drug
                       1.2.3. Service
                       1.2.4. Therapeutics Area
                       1.2.5. End Use
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased Database
                       1.4.2. GVR’s Internal Database
                       1.4.3. Secondary Sources
                       1.4.4. Primary Research
                   1.5. Information Or Data Analysis
                       1.5.1. Data Analysis Models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Commodity flow analysis
                       1.7.2. Value chain-based analysis
                       1.7.3. Multivariate Analysis
                   1.8. List of Secondary Sources
                   1.9. List of Abbreviations
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                   2.3. Competitive Insights
Chapter 3. U.S. Drug Discovery Outsourcing Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent Market Outlook
                       3.1.2. Related/Ancillary Market Outlook
                   3.2. Market Dynamics
                       3.2.1. Market Driver Analysis
                           3.2.1.1. Rising R&D cost in biopharmaceutical Industry
                           3.2.1.2. Increasing access to specialized expertise
                           3.2.1.3. Growing demand for outsourcing Services in Drug Development
                           3.2.1.4. Increasing number of partnerships in U.S. Drug Discovery research
                           3.2.1.5. Technological advancements in drug discovery
                       3.2.2. Market Restraint Analysis
                           3.2.2.1. Presence of open-source software packages for drug discovery
                           3.2.2.2. High manufacturing costs coupled with high risk of drug failure
                           3.2.2.3. Rising Data Security and IP Concerns
                           3.2.2.4. Regulatory and Compliance Risks
                   3.3. Clinical Trials Volume Analysis (2024)
                       3.3.1. Total Number of Clinical Trials, By Region
                       3.3.2. Total Number of Clinical Trials, By Phase
                       3.3.3. Total Number of Clinical Trials, By Study Design
                       3.3.4. Total Number of Clinical Trials, By Key Therapeutic Area
                   3.4. Pricing Model Analysis
                   3.5. Technology Landscape
                   3.6. Market Analysis Tools
                       3.6.1. Porter’s Five Force Analysis
                       3.6.2. PESTEL by SWOT Analysis
                       3.6.3. COVID-19 Impact Analysis
Chapter 4. U.S. Drug Discovery Outsourcing Market: Workflow Estimates & Trend Analysis
                   4.1. U.S. Drug Discovery Outsourcing Market, By Workflow: Segment Dashboard
                   4.2. U.S. Drug Discovery Outsourcing Market, By Workflow: Movement Analysis
                   4.3. U.S. Drug Discovery Outsourcing Market Estimates & Forecasts, By Workflow, 2021 - 2033 (USD Million)
                   4.4. Target Identification & Screening
                       4.4.1. Target Identification & Screening Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   4.5. Target Validation & Functional Informatics
                       4.5.1. Target Validation & Functional Informatics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   4.6. Lead Identification & Candidate Optimization
                       4.6.1. Lead Identification & Candidate Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   4.7. Preclinical Development
                       4.7.1. Preclinical Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   4.8. Others
                       4.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Drug Discovery Outsourcing Market: Drug Estimates & Trend Analysis
                   5.1. U.S. Drug Discovery Outsourcing Market, By Drug: Segment Dashboard
                   5.2. U.S. Drug Discovery Outsourcing Market, By Drug: Movement Analysis
                   5.3. U.S. Drug Discovery Outsourcing Market Estimates & Forecasts, By Drug, 2021 - 2033 (USD Million)
                   5.4. Small Molecules
                       5.4.1. Small Molecules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   5.5. Large Molecules
                       5.5.1. Large Molecules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Drug Discovery Outsourcing Market: Service Estimates & Trend Analysis
                   6.1. U.S. Drug Discovery Outsourcing Market, By Service: Segment Dashboard
                   6.2. U.S. Drug Discovery Outsourcing Market, By Service: Movement Analysis
                   6.3. U.S. Drug Discovery Outsourcing Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
                   6.4. Chemistry Services
                       6.4.1. Chemistry Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   6.5. Biology Services
                       6.5.1. Biology Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. U.S. Drug Discovery Outsourcing Market: Therapeutics Area Estimates & Trend Analysis
                   7.1. U.S. Drug Discovery Outsourcing Market, By Therapeutics Area: Segment Dashboard
                   7.2. U.S. Drug Discovery Outsourcing Market, By Therapeutics Area: Movement Analysis
                   7.3. U.S. Drug Discovery Outsourcing Market Estimates & Forecasts, By Therapeutics Area, 2021 - 2033 (USD Million)
                   7.4. Respiratory system
                       7.4.1. Respiratory System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   7.5. Pain and Anesthesia
                       7.5.1. Pain and Anesthesia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   7.6. Oncology
                       7.6.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   7.7. Ophthalmology
                       7.7.1. Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   7.8. Hematology
                       7.8.1. Hematology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   7.9. Cardiovascular
                       7.9.1. Cardiovascular Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   7.10. Endocrine
                       7.10.1. Endocrine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   7.11. Gastrointestinal
                       7.11.1. Gastrointestinal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   7.12. Immunomodulation
                       7.12.1. Immunomodulation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   7.13. Anti-infective
                       7.13.1. Anti-infective Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   7.14. Central Nervous System
                       7.14.1. Central Nervous System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   7.15. Dermatology
                       7.15.1. Dermatology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   7.16. Genitourinary System
                       7.16.1. Genitourinary System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. U.S. Drug Discovery Outsourcing Market: End Use Estimates & Trend Analysis
                   8.1. U.S. Drug Discovery Outsourcing Market, By End Use: Segment Dashboard
                   8.2. U.S. Drug Discovery Outsourcing Market, By End Use: Movement Analysis
                   8.3. U.S. Drug Discovery Outsourcing Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
                   8.4. Pharmaceutical & Biotechnology companies
                       8.4.1. Pharmaceutical & Biotechnology companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   8.5. Academic Institutes
                       8.5.1. Academic Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
                   9.1. Market Participant Categorization
                   9.2. Company Market Share/Assessment Analysis, 2024
                   9.3. Company Profiles
                       9.3.1. Albany Molecular Research Inc.
                           9.3.1.1. Company Overview
                           9.3.1.2. Financial Performance
                           9.3.1.3. Service Benchmarking
                           9.3.1.4. Strategic Initiatives
                       9.3.2. EVOTEC
                           9.3.2.1. Company Overview
                           9.3.2.2. Financial Performance
                           9.3.2.3. Service Benchmarking
                           9.3.2.4. Strategic Initiatives
                       9.3.3. Laboratory Corporation of America Holdings
                           9.3.3.1. Company Overview
                           9.3.3.2. Financial Performance
                           9.3.3.3. Service Benchmarking
                           9.3.3.4. Strategic Initiatives
                       9.3.4. GenScript
                           9.3.4.1. Company Overview
                           9.3.4.2. Financial Performance
                           9.3.4.3. Service Benchmarking
                           9.3.4.4. Strategic Initiatives
                       9.3.5. Pharmaceutical Product Development, LLC
                           9.3.5.1. Company Overview
                           9.3.5.2. Financial Performance
                           9.3.5.3. Service Benchmarking
                           9.3.5.4. Strategic Initiatives
                       9.3.6. Charles River Laboratories
                           9.3.6.1. Company Overview
                           9.3.6.2. Financial Performance
                           9.3.6.3. Service Benchmarking
                           9.3.6.4. Strategic Initiatives
                       9.3.7. WuXi AppTec
                           9.3.7.1. Company Overview
                           9.3.7.2. Financial Performance
                           9.3.7.3. Service Benchmarking
                           9.3.7.4. Strategic Initiatives
                       9.3.8. Thermo Fisher Scientific Inc.
                           9.3.8.1. Company Overview
                           9.3.8.2. Financial Performance
                           9.3.8.3. Service Benchmarking
                           9.3.8.4. Strategic Initiatives
                       9.3.9. Dalton Pharma Services
                           9.3.9.1. Company Overview
                           9.3.9.2. Financial Performance
                           9.3.9.3. Service Benchmarking
                           9.3.9.4. Strategic Initiatives
                       9.3.10. Oncodesign
                           9.3.10.1. Company Overview
                           9.3.10.2. Financial Performance
                           9.3.10.3. Service Benchmarking
                           9.3.10.4. Strategic Initiatives
                       9.3.11. Jubilant Biosys
                           9.3.11.1. Company Overview
                           9.3.11.2. Financial Performance
                           9.3.11.3. Service Benchmarking
                           9.3.11.4. Strategic Initiatives
                       9.3.12. DiscoverX Corp.
                           9.3.12.1. Company Overview
                           9.3.12.2. Financial Performance
                           9.3.12.3. Service Benchmarking
                           9.3.12.4. Strategic Initiatives
                       9.3.13. QIAGEN
                           9.3.13.1. Company Overview
                           9.3.13.2. Financial Performance
                           9.3.13.3. Service Benchmarking
                           9.3.13.4. Strategic Initiatives
                       9.3.14. Eurofins SE
                           9.3.14.1. Company Overview
                           9.3.14.2. Financial Performance
                           9.3.14.3. Service Benchmarking
                           9.3.14.4. Strategic Initiatives
                       9.3.15. Syngene International Limited
                           9.3.15.1. Company Overview
                           9.3.15.2. Financial Performance
                           9.3.15.3. Service Benchmarking
                           9.3.15.4. Strategic Initiatives
                       9.3.16. Dr. Reddy Laboratories Ltd.
                           9.3.16.1. Company Overview
                           9.3.16.2. Financial Performance
                           9.3.16.3. Service Benchmarking
                           9.3.16.4. Strategic Initiatives
                       9.3.17. Pharmaron Beijing Co., Ltd.
                           9.3.17.1. Company Overview
                           9.3.17.2. Financial Performance
                           9.3.17.3. Service Benchmarking
                           9.3.17.4. Strategic Initiatives
                       9.3.18. TCG Lifesciences Pvt Ltd.
                           9.3.18.1. Company Overview
                           9.3.18.2. Financial Performance
                           9.3.18.3. Service Benchmarking
                           9.3.18.4. Strategic Initiatives
                       9.3.19. Domainex Ltd.
                           9.3.19.1. Company Overview
                           9.3.19.2. Financial Performance
                           9.3.19.3. Service Benchmarking
                           9.3.19.4. Strategic Initiatives
Chapter 10. Key Recommendations

List of Tables

Table 1 List of Tables
Table 2 List of Secondary Sources
Table 3 List of Abbreviations
Table 4 U.S. Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 5 U.S. Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 6 U.S. Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 7 U.S. Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 8 U.S. Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 QFD model sizing & forecasting
Fig. 9 Bottom-up approach
Fig. 10 Market snapshot
Fig. 11 Segment snapshot 1
Fig. 12 Segment snapshot 2
Fig. 13 Competitive landscape snapshot
Fig. 14 Parent market outlook, 2024 (USD Billion)
Fig. 15 Ancillary market outlook, 2024 (USD Billion)
Fig. 16 U.S. Drug Discovery Outsourcing Market Dynamics
Fig. 17 Porter’s five forces analysis
Fig. 18 PESTEL analysis
Fig. 19 U.S. Drug Discovery Outsourcing Market: Workflow outlook and key takeaways
Fig. 20 U.S. Drug Discovery Outsourcing Market: Workflow movement analysis
Fig. 21 Target Identification & Screening Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 22 Target Validation & Functional Informatics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 23 Lead Identification & Candidate Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 24 Preclinical Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 25 Other Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 26 U.S. Drug Discovery Outsourcing Market: Drug outlook and key takeaways
Fig. 27 U.S. Drug Discovery Outsourcing Market: Drug movement analysis
Fig. 28 Small Molecules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 29 Large Molecules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 30 U.S. Drug Discovery Outsourcing Market: Service outlook and key takeaways
Fig. 31 U.S. Drug Discovery Outsourcing Market: Service movement analysis
Fig. 32 Chemistry Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 33 Biology Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 34 U.S. Drug Discovery Outsourcing Market: Therapeutics Area outlook and key takeaways
Fig. 35 U.S. Drug Discovery Outsourcing Market: Therapeutics Area movement analysis
Fig. 36 Respiratory system Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 37 Pain and Anesthesia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 38 Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 39 Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 40 Hematology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 41 Cardiovascular Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 42 Endocrine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 43 Gastrointestinal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 44 Immunomodulation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 45 Anti-infective Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 46 Central NervoU.S. System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 47 Dermatology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 48 Genitourinary System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 49 U.S. Drug Discovery Outsourcing Market: End Use outlook and key takeaways
Fig. 50 U.S. Drug Discovery Outsourcing Market: End Use movement analysis
Fig. 51 Pharmaceutical & Biotechnology companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 52 Academic Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 53 Key company categorization
Fig. 54 Service heat map analysis
Fig. 55 Strategic framework